Pfizer Drug Price Cuts Yield Three-Year Trump Tariff Respite, Lilly Deal Could Be Next

Pfizer secured a reprieve from President Donald Trump’s long-threatened tariffs on the pharmaceutical industry by agreeing to slash some of its drug prices by up to 85% and selling directly to the American public, a move other major drugmakers are expected to follow. In exchange, the company gained...

Redirecting to full article...